CAS 2671128-05-3 appears in our catalog under these names: FHD-286/ 98.7% (existing batch purity), FHD–286, FHD-286 98% 99.9+% ee, FHD-286, 98% 99.9+% ee, 98% 99.9+% ee, Camibirstat, 99.06%. Offered by: TargetMol, GLPBio, Ambeed, Chemat, MedChemExpress. Available pack sizes: 1mg, 5mg, 10mg, 25mg, 50mg, 100mg, 500mg, 250mg.
FHD-286 is a selective, oral inhibitor of SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor. FHD-286 has the potential for the research of BAF (BRG1/BRM-associated factor)-related disorders such as acute myeloid leukemia.
Source: ChEBI
| Molecular formula | C24H30N6O6S2 |
|---|---|
| Molecular weight | 562.7 g/mol |
| IUPAC name | N-[(2S)-1-[[4-[6-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-2-pyridinyl]-1,3-thiazol-2-yl]amino]-3-methoxy-1-oxopropan-2-yl]-1-methylsulfonylpyrrole-3-carboxamide |
| InChIKey | JBLQNFBXKOAIHG-FCEWJHQRSA-N |
| SMILES | C[C@@H]1CN(C[C@@H](O1)C)C2=CC=CC(=N2)C3=CSC(=N3)NC(=O)[C@H](COC)NC(=O)C4=CN(C=C4)S(=O)(=O)C |
Computed by PubChem (NCBI)